Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
08. Januar 2025 18:46 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that BioAge Labs, Inc. (BIOA) Misled Investors Regarding its Lead Drug Candidate in Connection with its IPO